Clinical Trial

Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy

Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, randomized, open-label, multicenter study is designed to evaluate the impact of an enhanced recovery after surgery (ERAS) protocol on the rate of meeting discharge criteria in patients undergoing minimally-invasive gastrectomy for gastric cancer. We hypothesize that implementation of our ERAS protocol will significantly increase the proportion of patients who meet standardized discharge criteria following minimally-invasive gastrectomy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-14; most recent amendment 2025-09-04.
Status change: Not Yet Recruiting → Recruiting 2025-09-04
Trial Details
NCT Number NCT06984952
Lead Sponsor Seoul National University Hospital
Collaborators: Seoul National University Bundang Hospital, Seoul National University Boramae Hospital, Severance Hospital, Chungnam National University Hospital, Keimyung University Dongsan Medical Center, National Cancer Center, Korea, The Catholic University of Korea, Ajou University School of Medicine, Pusan National University Hospital
Conditions Enhanced Recovery After Surgery, Gastrectomy for Gastric Cancer
Enrollment 308 participants
Start Date 2025-06-13
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-05